Pharma Mirror
MARCH 3, 2024
Presented by BetterHelp. Some people still aren’t aware that men and non-gestational parents can also experience emotional dysregulation after the birth of a child. Luckily, the conversation surrounding women and gestational parents and postpartum depression has gained a lot of awareness. However, are we forgetting the other half of the parenting dyad?
pharmaphorum
MARCH 3, 2024
Federal judge rules against AstraZeneca in lawsuit challenging Medicare drug pricing negotiation under the Inflation Reduction Act
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Patent Watch
MARCH 3, 2024
This chart shows the drugs with the most patents in Ukraine. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.… The post Which pharmaceutical drugs have the most drug patents in Ukraine? appeared first on DrugPatentWatch - Make Better Decisions.
pharmaphorum
MARCH 3, 2024
Avidity Biosciences files $400m private placement as it prepares for phase 3 trial of lead antibody oligonucleotide conjugate AOC 1001 in rare disease DM1
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
FDA Law Blog
MARCH 3, 2024
By Steven J. Gonzalez & JP Ellison — The most recent version of the BIOSECURE Act (the “Act”) was introduced in the U.S. House of Representatives ( H.B. 7085 ) and Senate ( S.B. 3558 ) on January 25, 2024. This proposed legislation should be of interest to any biotechnology companies that want to do business with the federal government in the future.
JAMA Internal Medicine
MARCH 3, 2024
This essay describes an intensive care and palliative medicine physician’s decision to elect medical aid in dying.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
JAMA Internal Medicine
MARCH 3, 2024
This Narrative Review summarizes current evidence and explores emerging science on the prevention and treatment of dementia to inform clinical decision-making.
JAMA Internal Medicine
MARCH 3, 2024
This JAMA Internal Medicine Patient Page describes memory loss and dementia and how they may be treated.
JAMA Internal Medicine
MARCH 3, 2024
This systematic review and meta-analysis summarizes current rates of central venous catheter–associated complications.
JAMA Internal Medicine
MARCH 3, 2024
This Viewpoint describes the positive role that primary care teams can play in the lives of patients with dementia and the families that care for them.
Expert insights. Personalized for you.
130 
Let's personalize your content